Clinical Impact of Olaparib for Platinum-Sensitive Recurrent Ovarian Cancer
<b>Background/Objectives</b>: Olaparib, a poly ADP ribose polymerase inhibitor, has been effective in prolonging progression-free survival in platinum-sensitive recurrent ovarian cancer. The clinicopathological factors that predict a favorable prognosis remain unclear. Therefore, we retr...
| Váldodahkkit: | , , , , , |
|---|---|
| Materiálatiipa: | Artihkal |
| Giella: | English |
| Almmustuhtton: |
MDPI AG
2025-02-01
|
| Ráidu: | Diseases |
| Fáttát: | |
| Liŋkkat: | https://www.mdpi.com/2079-9721/13/2/51 |